Niagen Bioscience, Inc. (NAGE) › Net IncomeNiagen Bioscience, Inc. (NAGE) — Net IncomeAnnual figures by fiscal year, from SEC filings.2011: -$7.89M2012: -$11.66M2013: -$4.42M2015: -$5.39M2016: -$2.93M2017: -$11.38M2018: -$33.32M2019: -$32.15M2020: -$19.93M2021: -$27.13M2022: -$16.54M2023: -$4.94M2024: $8.55M2025: $17.38M$17.38M2011Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$17.38M+103.3%2024$8.55M+273.1%2023-$4.94M+70.1%2022-$16.54M+39.0%2021-$27.13M-36.2%2020-$19.93M+38.0%2019-$32.15M+3.5%2018-$33.32M-192.8%2017-$11.38M-288.6%2016-$2.93M+45.7%2015-$5.39M—2013-$4.42M+62.1%2012-$11.66M-47.7%2011-$7.89M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share